Skip to content

Clinical trial of Sangsan Pu Gongying Drink to improve the clinical symptoms of patients infected with COVID-19

Clinical trial of Sangsan Pu Gongying Drink to improve the clinical symptoms of patients infected with COVID-19

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072150
Enrollment
Unknown
Registered
2023-06-05
Start date
2023-06-05
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection of COVID-19

Interventions

Test group:In addition to receiving routine treatment, the patient takes orally mulberry dandelion soup. Usage: 300ml (1 bottle) per bottle, taken orally for eight days. Adults drink 3 bottles per day
Control group: Routine treatment of COVID-19.

Sponsors

South China Hospital of Shenzhen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Age 18-90, gender unlimited; (2) Moderate or severe patients with COVID-19 infection or sequelae during recovery; (3) Agree to sign a written notice before the study begins.

Exclusion criteria

Exclusion criteria: (1) Patients with severe non-infectious pulmonary underlying diseases, including lung tumors, pulmonary edema, atelectasis, pulmonary embolism, pulmonary eosinophilic infiltration and pulmonary vasculitis; (2) patients with biliary tract and intestinal obstruction; (3) Pregnant women (urine or serum pregnancy test positive) or lactating women; (4) Patients with decoction intolerance were deemed unsuitable for inclusion in this study by other investigators, or there were any conditions that the investigators considered might increase the risk of the subjects or interfere with the clinical trial.

Design outcomes

Primary

MeasureTime frame
Number of days for nucleic acid test results to turn negative (infected patients);Improvement of clinical symptoms;Quality of life;Clinical test index - oxygen saturation before and after treatment;Clinical examination indicators - heart rate;Clinical laboratory examination index - respiratory rate;Clinical examination indicators - liver and kidney function;Clinical examination indicators - blood routine+CRP;Clinical laboratory examination indicators - CT imaging;

Countries

China

Contacts

Public ContactLi Yang

South China Hospital of Shenzhen University

lnq555@126.com+86 180 2622 4249

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026